Stay updated with breaking news from Celcuity Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
MINNEAPOLIS, June 03, 2024 -- Celcuity Inc. , a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced its participation in the Jefferies...
HC Wainwright reissued their buy rating on shares of Celcuity (NASDAQ:CELC – Free Report) in a report released on Thursday morning, Benzinga reports. They currently have a $27.00 price objective on the stock. HC Wainwright also issued estimates for Celcuity’s FY2028 earnings at $4.08 EPS. A number of other analysts also recently weighed in on […]
Craig Hallum reissued their buy rating on shares of Celcuity (NASDAQ:CELC – Free Report) in a research note issued to investors on Thursday, Marketbeat.com reports. The firm currently has a $27.00 target price on the stock, up from their previous target price of $25.00. Several other research firms have also commented on CELC. Needham & […]
Stifel Nicolaus reissued their buy rating on shares of Celcuity (NASDAQ:CELC – Free Report) in a report published on Thursday morning, Benzinga reports. They currently have a $40.00 price objective on the stock. A number of other research firms have also issued reports on CELC. Needham & Company LLC reissued a buy rating and set […]
Celcuity (NASDAQ:CELC – Get Free Report)‘s stock had its “buy” rating reiterated by equities research analysts at Needham & Company LLC in a report issued on Thursday, Benzinga reports. They presently have a $24.00 price target on the stock. Needham & Company LLC’s target price points to a potential upside of 39.29% from the stock’s […]